Divi's Laboratories Future Growth
Future criteria checks 4/6
Divi's Laboratories is forecast to grow earnings and revenue by 23.9% and 13.5% per annum respectively. EPS is expected to grow by 21.6% per annum. Return on equity is forecast to be 16% in 3 years.
Key information
23.9%
Earnings growth rate
21.6%
EPS growth rate
| Life Sciences earnings growth | 25.2% |
| Revenue growth rate | 13.5% |
| Future return on equity | 16.0% |
| Analyst coverage | Good |
| Last updated | 19 Apr 2024 |
Recent future growth updates
Recent updates
Shareholders Should Be Pleased With Divi's Laboratories Limited's (NSE:DIVISLAB) Price
Apr 19
Divi's Laboratories Limited (NSE:DIVISLAB) Not Flying Under The Radar
Dec 27Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00
Aug 04Divi's Laboratories (NSE:DIVISLAB) Will Pay A Dividend Of ₹30.00
Jul 20Divi's Laboratories (NSE:DIVISLAB) Has Announced A Dividend Of ₹30.00
Jul 06Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?
Nov 08Divi's Laboratories (NSE:DIVISLAB) Is Increasing Its Dividend To ₹30.00
Aug 04Divi's Laboratories' (NSE:DIVISLAB) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 21Divi's Laboratories (NSE:DIVISLAB) Will Pay A Larger Dividend Than Last Year At ₹30.00
Jul 07Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Might Deserve Your Attention Today
Jul 03Does Divi's Laboratories (NSE:DIVISLAB) Deserve A Spot On Your Watchlist?
Apr 03Should You Be Adding Divi's Laboratories (NSE:DIVISLAB) To Your Watchlist Today?
Dec 23With EPS Growth And More, Divi's Laboratories (NSE:DIVISLAB) Is Interesting
Sep 02Here's Why We Think Divi's Laboratories (NSE:DIVISLAB) Is Well Worth Watching
Mar 25Do Institutions Own Divi's Laboratories Limited (NSE:DIVISLAB) Shares?
Mar 10Who Has Been Selling Divi's Laboratories Limited (NSE:DIVISLAB) Shares?
Feb 23Is Divi's Laboratories' (NSE:DIVISLAB) Share Price Gain Of 216% Well Earned?
Jan 25
Is Divi's Laboratories Limited's(NSE:DIVISLAB) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jan 07Is Now The Time To Put Divi's Laboratories (NSE:DIVISLAB) On Your Watchlist?
Dec 20What Type Of Shareholders Own The Most Number of Divi's Laboratories Limited (NSE:DIVISLAB) Shares?
Dec 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 114,865 | 27,470 | 16,548 | N/A | 2 |
| 3/31/2026 | 102,505 | 25,170 | 12,500 | N/A | 21 |
| 3/31/2025 | 88,633 | 20,396 | 7,694 | N/A | 23 |
| 3/31/2024 | 76,786 | 15,416 | 8,985 | N/A | 23 |
| 12/31/2023 | 74,926 | 13,834 | N/A | N/A | N/A |
| 9/30/2023 | 73,456 | 13,314 | 7,927 | 15,127 | N/A |
| 6/30/2023 | 72,906 | 14,774 | N/A | N/A | N/A |
| 3/31/2023 | 77,676 | 18,234 | 19,867 | 24,597 | N/A |
| 12/31/2022 | 83,353 | 23,971 | N/A | N/A | N/A |
| 9/30/2022 | 91,208 | 29,925 | 22,153 | 28,404 | N/A |
| 6/30/2022 | 92,538 | 31,054 | N/A | N/A | N/A |
| 3/31/2022 | 89,599 | 29,605 | 11,986 | 19,118 | N/A |
| 12/31/2021 | 82,297 | 25,678 | N/A | N/A | N/A |
| 9/30/2021 | 74,379 | 21,362 | 4,760 | 13,465 | N/A |
| 6/30/2021 | 71,996 | 20,493 | N/A | N/A | N/A |
| 3/31/2021 | 69,695 | 19,843 | 10,367 | 19,469 | N/A |
| 12/31/2020 | 65,710 | 18,705 | N/A | N/A | N/A |
| 9/30/2020 | 62,658 | 17,590 | 10,714 | 20,167 | N/A |
| 6/30/2020 | 59,620 | 15,962 | N/A | N/A | N/A |
| 3/31/2020 | 53,945 | 13,765 | 327 | 12,159 | N/A |
| 12/31/2019 | 52,719 | 12,803 | N/A | N/A | N/A |
| 9/30/2019 | 52,356 | 13,106 | -3,430 | 7,962 | N/A |
| 6/30/2019 | 51,139 | 13,575 | N/A | N/A | N/A |
| 3/31/2019 | 49,463 | 13,527 | 2,212 | 9,543 | N/A |
| 3/31/2018 | 38,915 | 8,770 | 5,020 | 7,759 | N/A |
| 3/31/2017 | 40,643 | 10,604 | N/A | 11,504 | N/A |
| 3/31/2016 | 37,764 | 11,258 | N/A | 10,379 | N/A |
| 3/31/2015 | 31,049 | 8,515 | N/A | 8,263 | N/A |
| 3/31/2014 | 25,267 | 7,733 | N/A | 5,567 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DIVISLAB's forecast earnings growth (23.9% per year) is above the savings rate (6.7%).
Earnings vs Market: DIVISLAB's earnings (23.9% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: DIVISLAB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: DIVISLAB's revenue (13.5% per year) is forecast to grow faster than the Indian market (10.3% per year).
High Growth Revenue: DIVISLAB's revenue (13.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DIVISLAB's Return on Equity is forecast to be low in 3 years time (16%).